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ArticleLipid-Conjugated Rigidochromic Probe Discloses
Membrane Alteration in Model Cells of Krabbe
DiseaseGerardo Abbandonato,1 Barbara Storti,1 Ilaria Tonazzini,1 Martin Stöckl,2 Vinod Subramaniam,3,4
Costanza Montis,5 Riccardo Nifosı̀,1 Marco Cecchini,1 Giovanni Signore,1,6,* and Ranieri Bizzarri1,5,*
1NEST, Scuola Normale Superiore and Istituto Nanoscienze CNR (NANO-CNR), Piazza San Silvestro, Pisa, Italy; 2Bioimaging Center,
Department of Biology, Universit€at Konstanz, Konstanz, Germany; 3Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
4Nanobiophysics, MESAþ Institute for Nanotechnology and MIRA Institute for Biomedical Technology and Technical Medicine, University of
Twente, Enschede, The Netherlands; 5Department of Chemistry and CSGI, University of Florence, Florence, Italy; and 6Center for
Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Pisa, ItalyABSTRACT The plasma membrane of cells has a complex architecture based on the bidimensional liquid-crystalline bilayer
arrangement of phospho- and sphingolipids, which in turn embeds several proteins and is connected to the cytoskeleton.
Several studies highlight the spatial membrane organization into more ordered (Lo or lipid raft) and more disordered (Ld) do-
mains. We here report on a fluorescent analog of the green fluorescent protein chromophore that, when conjugated to a phos-
pholipid, enables the quantification of the Lo and Ld domains in living cells on account of its large fluorescence lifetime variation in
the two phases. The domain composition is straightforwardly obtained by the phasor approach to confocal fluorescence lifetime
imaging, a graphical method that does not require global fitting of the fluorescence decay in every spatial position of the sample.
Our imaging strategy was applied to recover the domain composition in human oligodendrocytes at rest and under treatment
with galactosylsphingosine (psychosine). Exogenous psychosine administration recapitulates many of the molecular fingerprints
of a severe neurological disease, globoid cell leukodystrophy, better known as Krabbe disease. We found out that psychosine
progressively destabilizes plasma membrane, as witnessed by a shrinking of the Lo fraction. The unchanged levels of galactosyl
ceramidase, i.e., the enzyme lacking in Krabbe disease, upon psychosine treatment suggest that psychosine alters the plasma
membrane structure by direct physical effect, as also recently demonstrated in model membranes.INTRODUCTIONThe composition and organization of the plasma membrane
(PM) is one of the most debated issues in biophysics, and its
description is enriched every year by new biomolecular de-
tails. The original fluid mosaic model and the liquid-crystal-
line interpretation have been overtaken by a spatially
interlaced combination of liquid-order (Lo, also referred to
as ‘‘lipid raft’’) and liquid-disorder (Ld) phases, enriched
respectively in saturated and unsaturated lipids, together
with different amounts of cholesterol (1–3). In its simplest
description, the ‘‘raft’’ model depicts the PM as a nanostruc-
tured dynamic assembly of Ld and Lo phases, which are not
separated by definite boundaries but organized around the
cytoskeletal network. A continuous exchange of proteins
and protein complexes occurs between the two phases,Submitted May 25, 2018, and accepted for publication November 16, 2018.
*Correspondence: giovanni.signore@sns.it or r.bizzarri@sns.it
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 2019 Biophysical Society.modulated also by the confining action of the cytoskeleton
(3). This paradigm of membrane assembly was proposed
to be at the basis of and influential in every membrane pro-
cess, such as formation of protein clusters, signal transduc-
tion, endocytosis, and cell polarization and motility (2–6).
The raft hypothesis stimulated developments of new tech-
niques for studying the properties and localization of Lo
and Ld phases in model and cellular membranes. In this
context, fluorescence microscopy offers high sensitivity
and low sample perturbation and has become one of the
most popular methods (1). Accordingly, in the last few
years, the number of published environmentally sensitive
fluorescent probes targeted to the membrane has been
growing rapidly. These kinds of probes display optical re-
sponses able to distinguish Lo and Ld because of the sensi-
tivity to different physicochemical properties of the two
phases, such as local polarity (solvatochromic probes) due
to hydration and protein presence and/or local viscosity
(molecular rotors, also referred to as rigidochromic probes)Biophysical Journal 116, 477–486, February 5, 2019 477
Abbandonato et al.due to lipid packing (7,8). Classical examples of solvato-
chromic membrane probes are Laurdan (9–12) and Prodan
(13), which distribute evenly between Lo and Ld phases,
showing strongly blue-shifted emission in the Lo phase of
model membranes. Recently, Laurdan was also applied to
studies of membrane rafts in live cells, although the data
analysis is complicated by the rapid internalization of this
dye (14) and the need for two-photon excitation. Other
important examples of solvatochromic membrane probes
are di-4-ANEPPDHQ and derivates (15), 3-hydroxichro-
mone dyes (i.e., F2N12S (16–18)), coumarins (19), Nile
Red, and NR12S derivate (20). On the other hand, most mo-
lecular rotors targeted to membrane are functionalized ana-
logs of julolidine (DCVJ, CCVJ) (21,22), BODIPY (23–25),
or NBD (26,27). Membrane-targeted rigidochromic probes
are widely used to probe the transition from the gel to
liquid-crystal phase or, in general, the microviscosity of
the phospholipid bilayers (25–28). In most cases, however,
available rigidochromic probes targeted to membranes dis-
played a narrow change of optical properties between the
two lipid phases and/or were fairly sensitive to composi-
tional features (e.g., the cholesterol content) as well as
changes in local polarity.
Recently, we demonstrated how a close derivative of the
green fluorescent protein (GFP) chromophore, Ge1, acts
as a dual probe of polarity and viscosity, providing fully de-
coupled fluorescence responses to these parameters (29). In
this work, we demonstrate that a lipid bioconjugate of Ge1,
Ge1L (Fig. 1), addresses most drawbacks of membrane-tar-
geted rigidochromic probes, thus offering a reliable means
to follow membrane assembly in biochemical studies.
Indeed, Ge1L is associated with distinct fluorescence life-
times when embedded in Lo or Ld phases. Such change
can be exploited to yield the Lo/Ld composition by phasor
analysis of fluorescence lifetime imaging (ph-FLIM), a
straightforward approach that relies on a simple graphical
analysis of spectral and lifetime fluorescence images when
observed in the frequency domain (30–34).
Exploiting its peculiar sensing capabilities, Ge1L has
been here applied to monitor the remodeling of the PM in
a model of Krabbe disease (KD) in vitro. KD (also known
as globoid cell leukodystrophy) is a rare, rapidly progressingFIGURE 1 Molecular structure of Ge1L.
478 Biophysical Journal 116, 477–486, February 5, 2019childhood leukodystrophy triggered by a deficit of the
lysosomal enzyme galactosylceramidase (GALC) and char-
acterized by the accumulation of galactosylsphingosine
(psychosine; PSY) in the nervous system. Exogenous PSY
administrated in vitro to glial cell lines, such as the
MO3.13 human oligodendrocytes, is known to recapitulate
many of the molecular fingerprints of the disease, including
cell death by apoptosis and oxidative stress activation (35).
Recently, a few studies showed that the balance between cell
membrane rafts and disordered regions are altered in KD
cells in vivo and in vitro (36). Dysregulations of pathways
related to membrane proteins were also demonstrated by
the same group (37). Significantly, our results confirm the
progressive membrane alteration of MO3.13 cells upon
PSY administration and support the use of Ge1L as an im-




sphingomyelin, and cholesterol were all from Avanti Polar Lipids
(Alabaster, AL). All other reagents were purchased from Sigma Aldrich
(St. Louis, MO) (reverse phase grade), and were used without further
purification.Synthetic procedure for Ge1L
The synthetic procedure for Ge1L is reported in (38).Solutions
Details on the preparation of solutions are reported in the Supporting Ma-
terials and Methods.Lipid vesicle preparation
Multilamellar vesicles
A dry lipid film (see below for composition) was prepared from a chloro-
form solution by evaporation. Homogeneous multilamellar vesicles were
prepared by hydrating the lipid film in 20 mM Hepes, 140 mM NaCl
(pH 7.4) by vortexing.
Large unilamellar vesicles
The multilamellar vesicles (see above) were subjected to five freeze-thaw
cycles (liquid N2/37
C) before being extruded 11 times through 100 nm
polycarbonate filters using a hand-held extruder (Avanti Polar Lipids).
Large unilamellar vesicle (LUV) diameters were checked by a Malvern
Dynamic Light Scattering system and resulted always in measurements be-
tween 100 and 120 nm.
Giant unilamellar vesicles
Giant unilamellar vesicles (GUVs) were prepared through electroforma-
tion. Briefly, 10 mL of a 0.5 mg/mL lipid mixture solution in CHCl3 (see
below for composition) was deposited on each of two indium tin oxide-
coated glass slides on the conductive side. CHCl3 was dried under vacuum
Rigidochromic Probe Targeted to Membraneovernight, and a dry lipid film on each sheet was obtained. The electrofor-
mation chamber was prepared, sandwiching the sheets with an O-ring sepa-
rating the lipid films. The chamber was filled with an aqueous solution of
sucrose 0.1 M, and the electrical contact between the sheets was provided
by putting on each sheet a copper tape connected to a pulse generator, set at
a sinusoidal alternating voltage of 10 Hz frequency and two Vpp amplitude
for 3 h at 60C. GUVs were employed within 3 h after preparation.Compositions of lipid phases
Homogeneous lipid phases were obtained by the following lipid
compositions:
Ld: POPC 100% (multilamellar vesicles, LUV, GUV).
Lo: DPPC/cholesterol 70/30 (39) or sphingomyelin/cholesterol/POPC
20/60/20 (40,41) (multilamellar vesicles, LUV).
Nonhomogeneous lipid phases (phase coexistence in vesicles) were
obtained by the following lipid compositions:
Ld/Lo: 1,2-distearoyl-sn-glycero-3-phosphocholine/1,2-dioleoyl-sn-
glycero-3-phosphocholine/cholesterol 40/32/28 (GUV) (42).
The chromophore/lipid molar ratio was 1:100 in all experiments.Cell cultures and treatment
Chinese hamster ovary (CHO) K1 cells were provided by American
Type Culture Collection (CCL-61; ATCC, Manassas, VA) and grown in
Dulbecco’s modified Eagle medium F-12 nutrient mix (DMEM/F-12)
supplemented with 10% FBS, 100 U/mL penicillin, and 100 mg/mL strep-
tomycin. All products were from Thermo Fisher (Waltham, MA). For live
imaging, 12  104 cells were plated 24 h before transfection onto a 35 mm
glass-bottom dish (WillCo-dish GWSt-3522; WillCo Beheer B.V., Amster-
dam, The Netherlands).
Human oligodendrocyte MO3.13 cells (Cat. No. CLU301-P; Tebu Bio,
Le-Perray-en-Yvelines, France) were maintained at 37C in humidified at-
mosphere containing 5% CO2 in high-glucose DMEM supplemented with
2 mM L-glutamine, 1% penicillin/streptomicyn, and 10% heat-inactivated
fetal bovine serum (FBS); all products were from Thermo Fisher. For exper-
iments, MO3.13 cells were seeded at 30,000 cells/cm2 in WillCo dishes,
and 24 h after plating, cells were washed two times with phosphate-buffered
saline and then cultured in 0.2% FBS medium (DMEM supplemented with
0.2% FBS, 2 mM L-glutamine, and 1% penicillin/streptomicyn). Then,
MO3.13 cells were cultured in 0.2% FBS medium (control) or treated
with psychosine (PSY) 10 mM for 15 min (PSY15) or for 24 h (PSY24)
(35). For selected experiments, cells were also treated with PSY 10 mM
for 24 h, then washed and cultured in control 0.2% FBS medium for 6 h
(PSY24/6). PSY (Sigma Aldrich) was dissolved in dimethyl sulfoxide; con-
trol cultures received the same quantity of dimethyl sulfoxide, which never
exceeded 0.1% v/v.Fluorescence imaging and lifetime
measurements
Fluorescence imaging and lifetime measurements were performed by
means of a Leica TCS SP5 SMD inverted confocal microscope (Leica Mi-
crosystems AG, Buffalo Grove, IL) equipped with an external pulsed diode
laser for excitation at 405 and 470 nm and a time-correleated single photon
counting acquisition card (PicoHarp 300; PicoQuant, Berlin, Germany)
connected to internal spectral detectors. Laser repetition rate was set to
40 Hz. Image size was 256  256 pixels, and scan speed was usually set
to 400 Hz (lines per second). The pinhole aperture was set to 1.0 Airy. Sam-
ples were imaged using a 100 1.5 NA oil immersion objective (Leica Mi-
crosystems). Emission was monitored in the 480–525 and 540–580 nmranges, using the built-in acousto-optical beam-splitter detection system
of the confocal microscope. Acquisitions lasted until 100–200 photons
per pixel were collected, at a photon-counting rate of 100–500 kHz. The
two acquired ranges allowed us to evaluate the generalized poloarization
while the lifetime analysis was performed on the joined channels. For
each condition, CHO cells (15–20) and MO3.13 cells (30–50) were treated
with 1 mg/mL of Ge1L in DMEM and imaged after 15 min upon adminis-
tration at 37C. At this temperature, Ge1L showed negligible internaliza-
tion by endocytosis for 1 h.Cholesterol depletion
According to the protocol reported in (43), CHO cells were incubated with
5 mMMbCD at 37C and 5% CO2 in the culture medium for different times
(1, 2, 3, and 6 h).GALC level quantification
MO3.13 cells were plated on standard six-well plates, treated as previously
reported, and lysed on ice by 120 mL/well of radioimmunoprecipitation
assay (R0278; Sigma Aldrich), containing protease and phosphatase inhib-
itors cocktail (cOmplete and PhosSTOP; Roche Diagnostics, Basel,
Switzerland). Cell lysates were centrifugated (15000  g for 15 min,
4C), and then the supernatants were tested for protein concentration by
a protein assay kit (Micro BCA, Pierce; Thermo Scientific). 10 mL of
each sample (on average, 10 mg of protein lysate was used per assay)
was tested for GALC assay. The GALC assay was performed with specific
synthetic fluorescent 6-hexadecanoylamino-4-methylumbelliferyl-b-D-gal-
actopyranoside (HMU) following procedures previously described (44).
Briefly, we performed the assay by mixing 10 mL of protein extract (10–
15 mg) with 20 mL of 50 mM HMU substrate (freshly suspended in 0.2 M
Na2HPO4/0.1M citric-acid buffer (pH 5.2) with 0.02% w/v of sodium
azide). Reactions were incubated 17 h at 37C and then stopped with
0.2 M glycine/NaOH-buffer (pH 10.7) with 0.2% Na-dodecylsulfate
(170 mL). After stopping the assay, 100 mL aliquots from the total solution
were transferred to 96-well plates for reading in a fluorescence plate reader
(GloMax multiplate reader; Promega, Madison, WI) at the wavelengths of
HMU (emission filter: 415–485 nm; excitation filter: ultraviolet 365 nm).
Each lysate was run in duplicate. Results were normalized for protein con-
tent and reported in % with respect to control condition.Statistical analysis on Lo of MO3.13
Lo fractions in MO3.13 are reported as average value 5 the standard error
of the mean (mean 5 standard error), obtained from n R 3 independent
experiments. Data were statistically analyzed by GraphPad PRISM 5.00
program (GraphPad Software; San Diego, CA). One-Way ANOVA (Dun-
nett’s multiple comparison test) analysis was used; the mean values ob-
tained in each repeated experiment were assumed to be normally
distributed about the true mean. Statistical significance refers to results
where p < 0.05 was obtained.Molecular dynamics simulations
Two different compositions of the lipid bilayer were simulated, one Ld with
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholin (POPC) as a model of
the disordered phase, the other Lo with DPPC and cholesterol (70:30) as
a model of the ordered phase. The starting configurations for the lipid
bilayer patches were obtained using the Membrane Builder at the
Charmm-Gui website (www.charmm-gui.org). Each leaflet of system Ld
contained 38 POPC molecules, whereas that of system Lo contained 13
cholesterol and 32 DPPC molecules. The systems were solvated in a
box of water molecules (4435 in system Ld and 3626 in system Lo), andBiophysical Journal 116, 477–486, February 5, 2019 479
Abbandonato et al.Naþ/Cl ions were added (corresponding to NaCl concentration of 0.2 M)
within the usual periodic boundary condition scheme. The Charmm36 force
field was used for the lipids in the bilayer and for the lipid tail of the Ge1L.
The TIP3P model was used for water molecules. For the chromophore part,
the charges and other force field parameters were adjusted starting from
those of Reuter et al. for the GFP chromophore (45) and from those sug-
gested by CgenFF (46) available online (https://cgenff.umaryland.edu/).
Some specific torsion angle parameters were reparameterized by compari-
son with QM-MP2 scans. Gromacs (47) was used to run the molecular dy-
namics simulations (version 5.0.5). The simulations were performed using a
2 fs time step, with constraints on the bond lengths by the LINCS algorithm.
A constant temperature (310 K) and pressure (one bar) ensemble was forced
by, respectively, the v-rescale thermostat (with separate thermostats for wa-
ter and the rest of the system) and the Parrinello-Rahman barostat (or Be-
rendsen in the initial equilibration stages) with semi-isotropic pressure
coupling, in which changes in the z direction are uncoupled to those in
the x-y plane, as appropriate for lipid bilayer systems. Temperature and
pressure time couplings were 0.2 and 5.0 ps, respectively. The Verlet cutoff
scheme was used, with a 1.2 nm cutoff for van der Waal’s and Coulomb
short-range interactions. The long-range Coulomb interactions were treated
with the usual particle mesh Ewald scheme. TheGe1Lmolecule was added
to the solvent part of the system. The lipid bilayers were partially denatured
by increasing the temperature to 450 K for 10 ns and then letting the system
gradually cool down to 310 K. This automatically led to the insertion of the
molecule into the lipid bilayer. The systems were then simulated for 300 ns.
The average surface area of the simulated lipid bilayer patches was 23.8
(0.6) nm2 for system Ld and 18.4 (0.2) nm
2 for system Lo. Extending the
simulations up to 500 ns did not result in any relevant change to the results
shown.RESULTS
Spectroscopic properties of Ge1L in solution and
in LUVs
At first, the spectroscopic properties of Ge1L were
evaluated in solvents and solvent mixtures with different po-
larities and viscosities. In the visible range of the electro-
magnetic spectrum, the absorption spectrum of Ge1L
peaks around 419 nm and displays poor dependence on
the solvent polarity (Table 1). Conversely, the fluorescence
emission ranges between 497 and 521 nm (Table 1), depend-
ing on the dielectric properties of the solvent (38). The fluo-
rescence decay of Ge1L is biexponential (Table 1), in
keeping with the peculiar emission photophysics of its fluo-
rogenic unit Ge1 that entails two concurring excited states
(29). Yet, time-resolved anisotropy measurements in tetra-
hydrofurane (THF) show a rotational correlation time (q)TABLE 1 Spectroscopic Properties of Ge1L in Solvents and
Lipid Phases
Solvent εa labs,max (nm) lem,max (nm) h (cP) t1 (ns) t2 (ns) % t1
CCl4 3.2 420.5 497 0.91 2.21 1.22 60
AcOEt 3.3 416.5 508 0.42 2.42 1.14 25
THF 2.7 420 507 0.48 1.71 0.97 61
IPA 2.4 420 518 2.06 1.85 0.75 13
MeOH 2.6 416 521 0.59 2.30 0.78 12
Lo – – 512 – 3.67 2.15 46
Ld – – 519 – 6.20 3.20 75
aMolar extinction coefficient (*10þ4).
480 Biophysical Journal 116, 477–486, February 5, 2019of 200 ps, much longer than expected for untargeted
Ge1 (1–10 ps). This finding suggests that in Ge1L, the lipid
tether somewhat restrains the rotational degrees of freedom
of the fluorogenic unit. The strong rigidochromism ofGe1L
is witnessed by the double-logarithmic lifetime versus vis-
cosity (Förster-Hoffman (48,49)) linear plot obtained in
mixtures of variable viscosity (Fig. 2 b).
Next, the spectral and rigidochromic properties of Ge1L
were investigated in LUVs of 100 nm diameter. LUVs are
classical in vitro models of cell membrane phases and are
frequently used to validate membrane probes (1,41).
LUVs were tested to investigate the optical response of
Ge1L in pure lipid environments, namely the Ld and Lo
phases (see Materials and Methods). Note that lipid compo-
sitions leading to homogeneous phases were carefully
selected in all cases, following (39,40). We observed that
the phase nature negligibly affects the spectral emission
properties of Ge1L. This complies with the similar dielec-
tric properties explored by Ge1L in the bilayer. Instead,
embedding the probe into the rigid bilayer environment
leads to rather long fluorescent lifetimes, still biexponentialFIGURE 2 Spectroscopic properties of Ge1L in solvents and solvent
mixtures with variable polarity and viscosity. (a) Absorption (dashed)
and emission (full) spectra in CCl4 (black), THF (gray), and isopropryl
alcohol (IPA, light gray). (b) Forster-Hoffmann plot: log(hti) vs. log(h) of
Ge1L in Triton X-100/isoamyl alcohol, THF/PEG400, and CCl4/polybu-
tene mixtures.
Rigidochromic Probe Targeted to Membranein nature (Table 1). Remarkably, however, Ge1L average
lifetimes differ by more than 3 ns between the Ld and Lo
domains (Table 1). This finding indicates that the intramo-
lecular twisting of Ge1L is much more hampered in Lo
than in Ld phases. Dynamic anisotropy measurements
support this picture because we measured t ¼ 15 ns in
Ld domains and t > 100 ns in Lo domains, in both cases
with the same intrinsic anisotropy r0 ¼ 0.34. For compar-
ison, r0 ¼ 0.35 in THF, demonstrating that the nature of
the medium does not affect the transition dipole moments
of Ge1L.
The emission properties of Ge1L were also assessed in
GUVs either characterized by homogeneous Ld phase or
Ld/Lo phase coexistence (42). Fluorescence analysis indi-
cated thatGe1L is much more emissive in Lo, with a relative
intensity ratio r¼ I(Ld)/I(Lo)¼ 0.185 0.01. Such an inten-






FðLoÞ  Kp; (1)
where ε stands for the extinction coefficient, F for the quan-
tum yield, and Kp is the partition ratio [Ge1L (Ld)]/[Ge1L
(Lo)].
On account of the poor sensitivity of Ge1L absorption to
the local environment, we can assume that εðLdÞ=εðLoÞy1.
Also, the ratio of quantum yields can be expressed by the ra-
tio of average lifetimes FðLdÞ=FðLoÞytðLdÞ=tðLoÞ ¼
0:52, under the reasonable hypothesis that the radiative life-
time is negligibly affected by the lipid environment. This
leads to Kp ¼ 0.35, i.e., Ge1L partitions more preferably
in Lo phase than in Ld, likely on account of the saturated
structure of its lipid tether.Molecular dynamics simulations
Molecular dynamics simulations of the Ge1L/LUV system
shed light over the observed rigidochromic behavior of the
probe in the Ld and Lo domains. In Ld domains, the fluoro-
genic unit of Ge1L positions approximately parallel to thelipid-water interface, and its center of mass is localized,
on average, at 0.8 nm underneath (Fig. 3 a).
Additionally, the amplitude of the distributions clearly in-
dicates some flexibility of the fluorogenic unit inside the
bilayer. Conversely, in Lo domains, the chromophore
‘‘kernel’’ slips down into the bilayer (the average position
of the center of mass is 1.4 nm below the polar phosphate
heads) and is characterized by poor flexibility (Fig. 3 b).
Notably, in Lo domains, the cholesterol molecules accumu-
late near the fluorogenic unit: the interaction with the hy-
droxyl group of cholesterol could explain the slightly
higher dielectric constant detected in Lo as compared to
Ld domains (ε ¼ 15–16 in Lo vs. ε ¼ 8–10 in Ld domains)
(38). The different flexibility of the fluorophore is also
confirmed by the dihedral angle distributions of both its
phenyl groups Phe1 and Phe2 (scheme 1), which in Lo re-
gions show sharp peaks at 0 and 180, respectively
(Fig. S1, a and b). Conversely, in the Ld phase, only a slight
bias appears between their orientations. In this case, the
steric effect of the ‘‘flagpole’’ hydrogen is more evident.
Finally, the obtained flip-flop frequencies (Fig. S1 c) are
Phe1(Lo) ¼ 0.00 ns1, Phe1(Ld) ¼ 0.04 ns1, Phe2(Lo) ¼
0.01 ns1, and Phe2(Ld) ¼ 0.28 ns1. These findings attest
that although the Phe1 is mostly blocked by the steric hin-
drance of the targeting lipid, Phe2 is very sensitive to the
different phase orders.ph-FLIM and membrane domain composition in
CHO
The strong sensitivity of Ge1L lifetime to the nature of the
lipid phase prompted us to evaluate ph-FLIM (30) as a
convenient means to spatially map the phase composition
in cell membranes. The phasor analysis represents, in a po-
lar two-dimensional plot (‘‘phasor plot’’ (50)), the cosine
(gi,j) and sine (si,j) Fourier transforms of the normalized
emission decay collected in each pixel i, j of an image.
For monoexponential decays, the phasor (gi,j, si,j) lies on a
semicircle (universal circle) of radius 1/2 and center (1/2,
0); for multiexponential decays, the phasor lies inside theFIGURE 3 Molecular dynamics of Ld or Lo ho-
mogeneous lipid bilayers embedding Ge1L. (a)
On the left, a representative snapshot of molecular
dynamics simulations of Ge1L interacting with Ld
phase; on the right, a histogram reporting the depth
within the bilayer of the lipid phosphate groups
(brown), the Ge1L phosphate head (yellow), the
imidazolinone ring (green), and the carboxymethyl
molecular tether (red) is shown. (b) Same as for (a)
but relevant to Lo phase (note that the snapshot is
on the right and the depth histogram on the left).
In light blue is the cholesterol hydoxyl distribution.
To see this figure in color, go online.
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FIGURE 5 ph-FLIM ofGe1L in the PM of CHO cells. (a) Temporal evo-
lution of the cholesterol depletion observed through Ge1L lifetime. The
colors of the images in panel (a) are relative to the phasor plot (b). The his-
tograms in (c) describe the trend of the calculated intensity fraction of
Ge1L in Lo phase during the extraction process (from red to green: control,
1, 2, 3, and 6 h). To see this figure in color, go online.
Abbandonato et al.semicircle. On the phasor plot, the combinations of distin-
guishable photophysical states, such as those determined
by Ld and Lo phases, follow a vectorial addition rule, regard-
less of the number of exponentials they entail (30,50,51).
Thus, the individual contributions of lipid phases to a given
membrane location can be quantified by simple vector
algebra starting from the reference phasors relevant to Ld
and Lo domains. To calibrate ph-FLIM, we obtained the
reference phasors by ph-FLIM ofGe1L embedded in multi-
lamellar vesicles characterized by homogeneous Ld or Lo
phases. The finite precision of our measurements and/or
the vesicle heterogeneity pinpointed a phasor distribution
for each phase whose mass center was taken as the reference
value (Fig. 4).
After calibration,Ge1L was put to the test to quantify the
phase domains of the PM of CHO cells. First, a colocaliza-
tion experiment between the marker DiIC18(5)-DS and
Ge1L confirmed that our probe selectively stains the PM
of the living cells (Fig. S2). Next, we carried out FLIM
and ph-FLIM analysis. The average lifetime of Ge1L in
the PM of CHO cells is 4.2 ns. Comparison of this value
with the lifetimes found in Lo and Ld phases (Table 1) sug-
gests the ‘‘interlaced’’ coexistence of the two domains, as
hypothesized for the modern model of the PM. Accordingly,
ph-FLIM highlighted a phasor cloud lying on the calibration
line that connects the Lo and Ld phases (Fig. S3). Vector
algebra led to fractional intensity compositions (i.e., the
fraction of emitted photons by Ge1L in each phase)
c(Lo)¼ 60% and c(Ld)¼ 40%. This result is in good agree-
ment with data obtained by other dyes such as Laurdan (52).
The relative abundances f(Lo) and f(Ld) of the two phases
were calculated from the intensity ratio r, according to
f ðLoÞ ¼ r  cðLoÞ
1þ r  cðLoÞ  cðLoÞ; f ðLdÞ ¼ 1 f ðLoÞ:
(2)
We found out f(Lo) ¼ 21% and f(Ld) ¼ 79%.
Cholesterol depletion of the PM was reflected in a signif-
icant shift of the phasor cloud in the plot (Fig. 5), in excel-FIGURE 4 Phasor plot of Ge1L in multilamellar vesicles whose compo-
sitions enable the homogeneous Ld or Lo phases.
482 Biophysical Journal 116, 477–486, February 5, 2019lent agreement with the expected gradual disappearance of
the ordered phase (20,43).Membrane domain composition in MO3.13
oligodendrocytes
We then applied Ge1L to study the PM in a model
of KD in vitro. MO3.13 human oligodendrocyte cells
were cultured in control conditions or treated with PSY
10mM (35,53) for different times: 15 min (PSY15), 24 h
(PSY24), or 24 h followed by a 6 h recovery in control con-
ditions (PSY24/6). In all conditions, the membrane Lo/Ld
ratio was measured by ph-FLIM using Ge1L.
The exposure to PSY induced a linearly decreasing trend
in fraction of Lo phase (Fig. 6 a) as compared to control.
FIGURE 6 (a) Quantification of Lo domain in cell membrane by Ge1L.
Mo3.13 cells were cultured in control conditions or treated with PSY 10 mM
for 15 min (PSY15), 24 h (PSY24), or 24 h followed by a 6 h recovery in
control conditions (PSY24/6). *p < 0.05 control vs. PSY24/6, one-way
ANOVA Dunnett’s test. (b) Level of GALC activity in MO3.13 cells in
different conditions (as above). The GALC assay was performed with
HMU, and results are reported in % in respect to control condition. In all
cases, error bars refer to 1 SD.
Rigidochromic Probe Targeted to MembraneThis behavior was visible in all the experiments (single
data sets are reported in Fig. S4). Notably, the presence
of PSY in the medium at the measurement time enhances
cell variability, as witnessed by the larger SDs detected
for PSY15 and PSY24. Removal of PSY in PSY24/6
diminishes cell variability, and the depletion of the Lo
phase due to PSY exposure becomes statistically significant
(p < 0.05 vs. control, one-way ANOVA, Dunnett’s test).
Concomitantly to ph-FLIM, we measured the level of the
GALC enzyme (i.e., the enzyme lacking in KD) in parallel
batches of MO3.13 cells treated in the same ways to verify
whether the change in membrane order was correlated to
GALC activity. Our findings highlight that GALC activity
is stable in the treated and untreated cells (Fig. 6 b). These
data suggest that GALC enzyme activity is not affected
by the destabilization of the PM in MO3.13 cells induced
by PSY.DISCUSSION
Fluorescence is a highly dynamic phenomenon occurring in
the ns timescale. This relatively long time window allows
for the occurrence of several processes that can strongly
modify the nature of emission, including nanoscale friction
by surrounding molecules (rigidochromism). Ge1L is a
lipid bioconjugate of an efficient and polarity-independent
rigidochromic probe, Ge1, which targets selectively the
PM of living cells. In the modern picture of the PM, the
coexistence of ordered and disordered domains appears to
be behind a variety of processes, such as formation of
protein clusters, signal transduction, endocytosis, cell polar-
ization, and motility (54). Accordingly, the detection of
membrane phase composition is a relevant target in
biophysics (1). We found that Ge1L partitions in both Ld
and Lo phases, in which it experiences rather different envi-
ronments in terms of local fluidity, as witnessed by a large
change in fluorescence lifetime. Our molecular dynamics
simulations afford a rational explanation for this phenome-
non: Ge1L pins deeply inside the bilayer in Lo domains,
whereupon it experiences a very rigid environment.
Conversely, the higher molecular flexibity experienced by
Ge1L in Ld phases is owed to the closer position of the flu-
orogenic unit to the lipid bilayer surface.
The large lifetime difference of Ge1L in lipid bilayers
identifies two ‘‘reference states’’ that can be usefully ex-
ploited by ph-FLIM (31,33). From these reference states
and the relative intensities of the dye therein, the simple
vectorial rules of ph-FLIM enable the straightforward deter-
mination of the fractions of Ld and Lo phases in each single
pixel after Ge1L imaging. When Ge1L stains the cell mem-
brane, ph-FLIM measurement of Ld and Lo fractions is a
suitable way to construct a map of cell membrane composi-
tion. We note that the typical diffraction-limit resolution of a
wide-field fluorescence or confocal microscope operating
with visible light is, at most, around 200 nm. This means
that the lifetime from each pixel reflects an average of Ld
and Lo phases, whose dimensions were identified below
50 nm by several authors (3,55,56), although this figure is
still a matter of debate, and the actual value is unknown.
Notably, Kuimova et al. proposed the same ph-FLIM
approach for a different molecular rotor, although they did
not provide a quantitative estimate of the two phases in
living cells (57,58).
It is worth noting that the homogeneous lipid systems
used to calibrate Ld and Lo phases in ph-FLIM are simplistic
representations of the actual Ld and Lo nanophases in cells,
which both contain proteins, cholesterol, variable amounts
of charged lipids, and other biomolecules. Yet, for calibra-
tion, we need a stable model system in which we know,
for sure, that we have homogeneous (‘‘pure’’) phases. Any-
thing closer to the real lipid composition already may intro-
duce nanodomains. Giant PM vesicles, for example, show
phase separation, but this does not show up in the lifetimeBiophysical Journal 116, 477–486, February 5, 2019 483
Abbandonato et al.histogram, as previously reported by some of us (27). As
previously stated, our phasor calibration method identifies
two pure ‘‘states’’ and predicts that any mixture of these
two states would fall along their connection line in the pha-
sor plot. Remarkably, phasors ofGe1L in cell membrane do
fall along this line, substantiating the strong effect on life-
time by the local phase composition. However, this does
not imply that the two ideal states are actually there, but
rather that we can interpret the composition in any mem-
brane point as ideally made up of two limit pure phases.
Actually, the strength of ph-FLIM applied to Ge1L resides
in our capability to relate membrane changes to real compo-
sition shifts toward one or the other of the two pure phases,
yielding a biological insight. Our experiments on cells attest
to that.
At first, Ge1L was simply applied to analyze the mem-
brane of reference CHO cells. There, we found out that
the Lo phase accounts for 21% of the recorded intensity,
and this fraction is critically dependent on the available
cholesterol. In more biologically insightful experiments,
Ge1L highlighted the membrane alteration in MO3.13 hu-
man oligodendrocyte provoked by PSY, the cytotoxic sphin-
golipid that accumulates in the nervous system in KD owing
to loss of GALC activity. Data reported in Fig. 6, along with
the single experiment data sets (Fig. S4), show that PSY
administration to MO3.13 cells destabilizes the membrane,
supported by the rather large variation of phase composi-
tions measured when the cells are exposed and imaged in
the presence of PSY. Importantly, our findings reveal the
shrinking of the Lo phase along with PSY exposure. This
decrease is partially hidden by data variability for PSY15
and PSY24 conditions, but it becomes statistically signifi-
cant when PSY is removed after 24 h of exposure and cells
are allowed to recover for 6 h (PSY24/6). Additionally, PSY
effect seems unrelated to GALC activity, thus excluding a
feedback action of PSY-induced membrane alteration
against the accumulation of PSY. The latter data suggest
that prolonged exposure to PSY might induce irreversible
alterations in the PM, far beyond the possibility of rescue
by endogenous GALC.
The PM changes upon PSY treatment were recently
addressed by biochemical means. In all cases, PSY was
found to induce significant lipid raft alteration and slight
enrichment of cholesterol (36,37,59). Significantly, the
non-natural enantiomer of PSY (ent-PSY) was found to
have equal or greater toxicity compared with PSY (60).
This strongly suggests that PSY exerts its toxic action
through a nonenantioselective mechanism, possibly
through membrane perturbation rather than through ste-
reospecific protein-PSY interactions. In keeping with this
hypothesis, Diaz et al. very recently reported that PSY re-
models physically model lipid membranes at neutral pH
(61). Actually, they found out that PSY reduces the
compactness of the membrane and increases the fraction
of the disordered phase.484 Biophysical Journal 116, 477–486, February 5, 2019The in cellulo reduction of Lo phases that we observed
upon PSY administration fits very well in this context, rep-
resenting the first proof, to our knowledge, of the physical
action of PSY on actual PM. Our findings, also, are not
contradictory with the reduction of lateral mobility
observed by some authors in the myelin membrane upon
PSY treatment (36). Indeed, PSY intercalation in the
ordered domains leads to the loss of several raft proteins
(e.g., caveolin-1) that are apparently displaced by the toxic
lipid. Ge1L could be forced out of the altered ordered
domains, signaling the shrinking of the Lo phase. At any
rate, our experimental results add new insights into this
puzzling scenario, directly linking the previous observa-
tions about KD raft composition alteration to a physical
property of the membrane, which we could directly mea-
sure thanks to the Ge1L probe.CONCLUSIONS
We here reported on a fluorescent analog of the GFP chro-
mophore that, when conjugated to a phospholipid, enables
the quantification of the Lo and Ld domains in living cells
on account of its large fluorescence lifetime variation in
the two phases. The lifetime variation stems from a different
rigidochromic effect on the fluorogenic unit of Ge1L due to
the dissimilar arrangement of the probe in Lo and Ld do-
mains, as demonstrated by molecular dynamics simulations.
We note that spatially resolved quantification of Lo and Ld
domains is a relevant goal in fluorescence microscopy of
living cells on account of the regulating role of the two
bilayer phases on several biological processes. Indeed,
many approaches have been proposed to achieve this goal.
The advantage of our Ge1L probe lies in the combination
of excitation and emission in the visible range of electro-
magnetic spectrum (for instance, the popular membrane
probe Laurdan requires ultraviolet or two-photon excita-
tion), with high sensitivity to the two phases by a rigidochro-
mic effect on its lifetime. Additionally, the use of ph-FLIM
leads to a straightforward, all-graphic determination of Lo
and Ld composition in each pixel. Our imaging strategy
was applied to unveil the effect of PSY administration to
human oligodendrocytes, a simple in vitro model of KD
that nonetheless recapitulates most of the molecular pheno-
types associated with this pathology. We observed that PSY
progressively destabilizes the PM, as witnessed by a shrink-
ing of the Lo fraction. The unchanged levels of GALC, i.e.,
the enzyme lacking in KD, upon PSY treatment suggest
that PSY alters the PM structure by a direct physical effect,
possibly without altering the lipid metabolism of the
cell. This confirms experiments by Hawkins-Salsbury et al.
(60) that highlighted similar membrane destabilization
effects by PSY and its non-natural enantiomer that are
not recognized by the stereospecific cell machinery. We
believe that Ge1L represents a, to our knowledge, novel
remarkable molecular fluorescent indicator to monitor, with
Rigidochromic Probe Targeted to Membranesub-micrometer spatial resolution, any biological process that
leads to membrane remodeling and/or destabilization.SUPPORTING MATERIAL
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25. López-Duarte, I., T. T. Vu,., M. K. Kuimova. 2014. A molecular rotor
for measuring viscosity in plasma membranes of live cells. Chem.
Commun. (Camb.). 50:5282–5284.
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57. Dent, M. R., I. López-Duarte, ., M. K. Kuimova. 2016. Imaging
plasma membrane phase behaviour in live cells using a thiophene-
based molecular rotor. Chem. Commun. (Camb.). 52:13269–13272.
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